News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
168,362 Results
Type
Article (6772)
Company Profile (110)
Press Release (161480)
Section
Business (53817)
Career Advice (354)
Deals (9760)
Drug Delivery (30)
Drug Development (31962)
Employer Resources (68)
FDA (2723)
Job Trends (4136)
News (96488)
Policy (6750)
Tag
Academia (255)
Alliances (12262)
Alzheimer's disease (374)
Antibody-drug conjugate (ADC) (44)
Approvals (2736)
Artificial intelligence (61)
Bankruptcy (63)
Best Places to Work (3219)
Biotechnology (72)
Breast cancer (48)
Cancer (524)
Career advice (301)
CAR-T (45)
Cell therapy (114)
Clinical research (26861)
Collaboration (229)
Compensation (206)
COVID-19 (649)
C-suite (76)
Data (594)
Diabetes (51)
Diagnostics (599)
Earnings (22749)
Employer resources (59)
Events (33519)
Executive appointments (250)
FDA (2984)
Funding (168)
Gene therapy (59)
GLP-1 (231)
Government (717)
Healthcare (2299)
Infectious disease (673)
Inflammatory bowel disease (44)
Interviews (57)
IPO (5759)
Job creations (1024)
Job search strategy (259)
Layoffs (122)
Legal (907)
Lung cancer (89)
Manufacturing (94)
Medical device (442)
Medtech (443)
Mergers & acquisitions (4190)
Metabolic disorders (184)
Neuroscience (514)
NextGen: Class of 2025 (978)
Non-profit (238)
Northern California (876)
Obesity (96)
Opinion (75)
Patents (53)
People (17117)
Phase I (8130)
Phase II (12385)
Phase III (9019)
Pipeline (301)
Policy (49)
Postmarket research (510)
Preclinical (3022)
Radiopharmaceuticals (109)
Rare diseases (86)
Real estate (1199)
Regulatory (5618)
Research institute (280)
Southern California (685)
Startups (957)
United States (6575)
Vaccines (143)
Weight loss (53)
Date
Today (41)
Last 7 days (223)
Last 30 days (886)
Last 365 days (12310)
2025 (1554)
2024 (12551)
2023 (14346)
2022 (16202)
2021 (17844)
2020 (15213)
2019 (10001)
2018 (7150)
2017 (8949)
2016 (7309)
2015 (9302)
2014 (7062)
2013 (5085)
2012 (4915)
2011 (4844)
2010 (4810)
Location
Africa (165)
Asia (13424)
Australia (1465)
California (1820)
Canada (449)
China (243)
Colorado (66)
Connecticut (78)
Delaware (61)
Europe (24309)
Florida (223)
Georgia (53)
Illinois (87)
Indiana (65)
Japan (49)
Kansas (48)
Maryland (200)
Massachusetts (1457)
Minnesota (64)
New Jersey (656)
New York (621)
North Carolina (319)
Northern California (876)
Ohio (60)
Pennsylvania (329)
South America (209)
Southern California (685)
Texas (187)
Washington State (129)
168,362 Results for "arbutus biopharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
Arbutus Biopharma Corporation today issued the following statement regarding the claim construction ruling of the U.S. District Court for the District of Delaware in the lawsuit brought by Arbutus and its licensee Genevant Sciences (Plaintiffs) against Moderna.
April 4, 2024
·
5 min read
Pharm Country
Arbutus to Participate in Jefferies Global Healthcare Conference
Arbutus Biopharma Corporation today announced that the Arbutus management team will present at and host one-on-one meetings at the following upcoming investor conference being held in New York.
May 29, 2024
·
1 min read
Press Releases
Arbutus Provides 2025 Corporate and Financial Update
January 14, 2025
·
11 min read
Pharm Country
Arbutus to Participate in Two Upcoming May 2024 Investor Conferences
Arbutus Biopharma Corporation announced that the Arbutus management team will participate in and host one-on-one meetings at the following two upcoming investor conferences which are being held in New York.
May 7, 2024
·
1 min read
Bankruptcy
Biopharma Bankruptcies Still At Peak, With Little Relief in Sight
2023 marked the most bankruptcies in biopharma in more than a decade, with 14 companies filing for Chapter 11 protection. The number remained high in 2024.
February 19, 2025
·
5 min read
·
Annalee Armstrong
NextGen
BioSpace
’s NextGen Class of 2025 Leans Into Biopharma’s Hottest Trends
From ADCs and radiopharmaceuticals to cell and gene therapies, eager young startups are betting on advances in biopharma’s most competitive therapeutic spaces—and attracting dollars from Big Pharma.
January 7, 2025
·
5 min read
·
Heather McKenzie
Career Advice
The Top 12 Companies Hiring in Biopharma Now
Looking for a biopharma job? Check out the
BioSpace
list of 12 top companies hiring life sciences professionals like you.
February 6, 2025
·
1 min read
·
Angela Gabriel
Pharm Country
Arbutus to Present Imdusiran Data at EASL Congress 2024
Arbutus Biopharma Corporation announced that two abstracts have been accepted for poster and oral presentations at the European Association for the Study of the Liver Congress 2024 taking place June 5 - 8, 2024 in Milan, Italy.
May 22, 2024
·
6 min read
Business
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
Arbutus Biopharma Corporation today reports first quarter 2024 financial results and provides a corporate update.
May 2, 2024
·
17 min read
Collaboration
The Top 7 Biopharma Licensing Deals of 2024
Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in licensing deals, on average, than in 2023 with an eye toward enriching their pipelines with novel and potentially more effective therapies.
February 5, 2025
·
8 min read
·
Tristan Manalac
1 of 16,837
Next
